Synergy CHC Corp. — Director's Dealing 2016

Dec 23, 2016

SEC Form 4/A — Form 4/A

Issuer: Synergy CHC Corp. (SNYR)
CIK: 0001562733
Period of Report: 2016-12-22

Reporting Person: Knight Therapeutics (Barbados) Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-22	Common Stock	J	7500000	—	Acquired	17645812	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-22	Warrants	$0.34	J	1	Acquired	2025-01-22	Common Shares (3584759)	Direct
2016-12-22	Warrants	$0.49	J	1	Acquired	2025-11-12	Common Shares (4547243)	Direct
2016-12-22	Stock Options	$0.25	J	1	Acquired	2025-12-14	Common Shares (1000000)	Direct

Footnotes

F1: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer.